The Section of Clinical Sciences in the Division of Rheumatology, Immunology and Allergy consists of investigators who are leaders in the field of clinical population sciences research. Members of the section investigate a vast array of topics including risk factors and outcomes in rheumatoid arthritis (RA) and systemic lupus erythematosus (lupus), orthopedics outcome research, Lyme disease and drug safety of anti-rheumatic drugs. A Clinical Trials Center is currently under development as part of the Section.
Housed in the historic Boston Lying-In Building, next to Harvard Medical School and the Harvard School of Public Health, the Section is strategically located to facilitate dynamic interactions between clinicians, basic scientists, clinical investigators and public health scientists. Members of the Section have over 30 years experience in innovative methods and study designs in the rheumatic diseases.
The Section was established within the Division of Rheumatology, Immunology and Allergy in 2002, with Dr. Jeffrey N. Katz as founding Section Chief. In 2007, Dr. Daniel H. Solomon became Section Chief. The Section builds on the model and structure for clinical research first established in 1977 by Dr. Matthew Liang as the Robert B. Brigham Multipurpose Arthritis Center, a NIAMS P60 program.
Send Feedback to: Danielle Gillmer
This page was last modified on 10/19/2011